Raymond James & Associates Purchases 128,693 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT)

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Raymond James & Associates lifted its stake in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Free Report) by 39.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 454,360 shares of the oil and gas company's stock after acquiring an additional 128,693 shares during the period. Raymond James & Associates owned 0.57% of Calumet Specialty Products Partners worth $8,119,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Tower Research Capital LLC TRC lifted its stake in Calumet Specialty Products Partners by 335.3% during the first quarter. Tower Research Capital LLC TRC now owns 1,689 shares of the oil and gas company's stock valued at $29,000 after purchasing an additional 1,301 shares during the last quarter. IFP Advisors Inc purchased a new stake in shares of Calumet Specialty Products Partners in the 2nd quarter valued at approximately $32,000. Worth Asset Management LLC purchased a new stake in shares of Calumet Specialty Products Partners in the 1st quarter valued at approximately $54,000. BNP Paribas Arbitrage SA purchased a new stake in shares of Calumet Specialty Products Partners in the 2nd quarter valued at approximately $76,000. Finally, Covestor Ltd purchased a new stake in shares of Calumet Specialty Products Partners in the 1st quarter valued at approximately $77,000. 34.41% of the stock is owned by institutional investors and hedge funds.


Analyst Upgrades and Downgrades

CLMT has been the topic of several research reports. StockNews.com assumed coverage on shares of Calumet Specialty Products Partners in a research note on Saturday. They issued a "hold" rating on the stock. TheStreet upgraded shares of Calumet Specialty Products Partners from a "d+" rating to a "c-" rating in a research report on Monday, December 11th. Finally, The Goldman Sachs Group cut their target price on shares of Calumet Specialty Products Partners from $19.00 to $17.00 and set a "buy" rating for the company in a research report on Thursday, March 21st.

Read Our Latest Research Report on Calumet Specialty Products Partners

Insider Buying and Selling at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, Director Stephen P. Mawer sold 15,037 shares of the business's stock in a transaction dated Thursday, January 18th. The shares were sold at an average price of $17.87, for a total value of $268,711.19. Following the completion of the transaction, the director now directly owns 172,610 shares of the company's stock, valued at $3,084,540.70. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 2.91% of the company's stock.

Calumet Specialty Products Partners Stock Up 0.6 %

NASDAQ CLMT traded up $0.10 during midday trading on Monday, hitting $15.53. The company had a trading volume of 63,605 shares, compared to its average volume of 120,457. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of 19.66 and a beta of 1.76. The firm has a fifty day simple moving average of $15.54 and a two-hundred day simple moving average of $16.20. Calumet Specialty Products Partners, L.P. has a fifty-two week low of $11.91 and a fifty-two week high of $19.91.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last issued its earnings results on Friday, February 23rd. The oil and gas company reported ($0.59) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.40). The firm had revenue of $976.50 million for the quarter, compared to analyst estimates of $856.71 million. During the same quarter in the prior year, the business posted ($0.21) EPS. The business's quarterly revenue was down 2.3% compared to the same quarter last year. As a group, equities analysts predict that Calumet Specialty Products Partners, L.P. will post -0.52 earnings per share for the current year.

Calumet Specialty Products Partners Company Profile

(Free Report)

Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Performance brands; Montana/Renewables; and Corporate segments.

Recommended Stories

Institutional Ownership by Quarter for Calumet Specialty Products Partners (NASDAQ:CLMT)

→ Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad)

Should you invest $1,000 in Calumet Specialty Products Partners right now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: